These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3052814)

  • 1. Factors that may effect the reduction of hunger and body weight following d-fenfluramine administration.
    Campbell DB; Gordon BH; Ings RM; Richards R; Taylor DW
    Clin Neuropharmacol; 1988; 11 Suppl 1():S160-72. PubMed ID: 3052814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with fenfluramine in obese subjects.
    Sensi S; Della Loggia F; Del Ponte A; Guagnano MT
    Int J Clin Pharmacol Res; 1985; 5(4):247-53. PubMed ID: 4055167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Night eating syndrome is associated with depression, low self-esteem, reduced daytime hunger, and less weight loss in obese outpatients.
    Gluck ME; Geliebter A; Satov T
    Obes Res; 2001 Apr; 9(4):264-7. PubMed ID: 11331430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is it possible to obtain a reduction of body weight exclusively via a loss in fat mass? Experience with d-fenfluramine].
    Del Ponte A; D'Orazio N; Di Giacomo G; Tritella T; Bitti G; Martines G
    Recenti Prog Med; 1993 Feb; 84(2):100-5. PubMed ID: 8465086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activity of fenfluramine in obese subjects. Relation between dosage, plasma concentration of the drug and its effect on weight loss].
    Magnoni V; Boni S; Bonini LM; Zecca L; Bareggi SR
    Minerva Med; 1982 Jun; 73(24):1703-10. PubMed ID: 7088388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenfluramine treatment in female rats accelerates the weight loss associated with activity-based anorexia.
    Atchley DP; Eckel LA
    Pharmacol Biochem Behav; 2005 Feb; 80(2):273-9. PubMed ID: 15680180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diet rich in long chain omega-3 fatty acids modulates satiety in overweight and obese volunteers during weight loss.
    Parra D; Ramel A; Bandarra N; Kiely M; Martínez JA; Thorsdottir I
    Appetite; 2008 Nov; 51(3):676-80. PubMed ID: 18602429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects.
    Kamphuis MM; Lejeune MP; Saris WH; Westerterp-Plantenga MS
    Eur J Clin Nutr; 2003 Oct; 57(10):1268-74. PubMed ID: 14506488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects.
    Näslund E; King N; Mansten S; Adner N; Holst JJ; Gutniak M; Hellström PM
    Br J Nutr; 2004 Mar; 91(3):439-46. PubMed ID: 15005830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects.
    Adam TC; Jocken J; Westerterp-Plantenga MS
    Obes Res; 2005 Apr; 13(4):710-6. PubMed ID: 15897480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using intranasal lidocaine to reduce food intake.
    Greenway FL; Martin CK; Gupta AK; Cruickshank S; Whitehouse J; DeYoung L; Kamdar K; Caruso MK; Roberts AT; England M; Dumas K; Laidlaw BJ; Rogers B; Cowley MA
    Int J Obes (Lond); 2007 May; 31(5):858-63. PubMed ID: 17130849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.
    Zelissen PM; Stenlof K; Lean ME; Fogteloo J; Keulen ET; Wilding J; Finer N; Rössner S; Lawrence E; Fletcher C; McCamish M;
    Diabetes Obes Metab; 2005 Nov; 7(6):755-61. PubMed ID: 16219020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hunger, food intake and weight: the impact of clomipramine on a refeeding anorexia nervosa population.
    Lacey JH; Crisp AH
    Postgrad Med J; 1980; 56 Suppl 1():79-85. PubMed ID: 6994086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination.
    Weintraub M; Hasday JD; Mushlin AI; Lockwood DH
    Arch Intern Med; 1984 Jun; 144(6):1143-8. PubMed ID: 6375610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of dexfenfluramine in obese patients: a multicenter study.
    Enzi G; Crepaldi G; Inelmen EM; Bruni R; Baggio B
    Clin Neuropharmacol; 1988; 11 Suppl 1():S173-8. PubMed ID: 3052815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
    Mitchell JE; Gosnell BA; Roerig JL; de Zwaan M; Wonderlich SA; Crosby RD; Burgard MA; Wambach BN
    Obes Res; 2003 May; 11(5):599-602. PubMed ID: 12740447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessing various aspects of the motivation to eat that can affect food intake and body weight control].
    Bellisle F
    Encephale; 2009 Apr; 35(2):182-5. PubMed ID: 19393389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year ad libitum consumption of diacylglycerol oil as part of a regular diet results in modest weight loss in comparison with consumption of a triacylglycerol control oil in overweight Japanese subjects.
    Kawashima H; Takase H; Yasunaga K; Wakaki Y; Katsuragi Y; Mori K; Yamaguchi T; Hase T; Matsuo N; Yasukawa T; Tokimitsu I; Koyama W
    J Am Diet Assoc; 2008 Jan; 108(1):57-66. PubMed ID: 18155990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of consumption of a novel fat emulsion in relation to body-weight management.
    Diepvens K; Soenen S; Steijns J; Arnold M; Westerterp-Plantenga M
    Int J Obes (Lond); 2007 Jun; 31(6):942-9. PubMed ID: 17299383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.